XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

18,400 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 17,438
R4B: 0
R5: 438
R6: 0

By Authority

none: 1,998
hl7: 16,400
national: 2

Start Prev Rows 8600 - 8800 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.40	Advance Care Planning Documentation	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.41	Advance Care Planning Documentation	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.42	Healthcare Agent & Power of Attorney Documentation	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.43	Advance Directive Documentation	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.45	Advance Care Planning Documentation	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.46	Advance Care Planning Documentation	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.47	Portable Medical Order(s) Documentation	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.48	Portable Medical Order(s) Documentation	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.49	Intervention for Positive Utility Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.5	Allergy to thrombolytics	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.50	Intervention for Positive Utility Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.51	Intervention for Positive Transportation Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.52	Intervention for Positive Transportation Insecurity Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.53	Intervention for Positive Housing Instability Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.54	Intervention for Positive Housing Instability Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.55	Intervention for Positive Homelessness Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.56	Intervention for Positive Homelessness Screen	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.57	Non Invasive Oxygen Therapy Device Codes	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.58	Goals, preferences, and priorities for medical treatment	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.6	Thrombolytics Adverse Event	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.7	Intraspinal surgery	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1176.58	Food Insecurity Screening Positive	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.1	Ezetimibe Therapy	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.10	Antihypertensive Medications	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.100	Allergy or Intolerance to ACE Medication	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.101	Allergy or Intolerance to ARB Medication	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.102	Chronic Kidney Disease Stage 1	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.103	Chronic Kidney Disease Stage 2	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.104	Chronic Kidney Disease Stage 3	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.105	Chronic Kidney Disease Stage 4	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.106	Chronic Kidney Disease Stage 5	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.107	ICD10 CM Chronic Kidney Disease Stage 1	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.108	ICD10 CM Chronic Kidney Disease Stage 2	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.111	AHA GWTG Chronic Kidney Disease Stage 2	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.112	ICD10 CM Chronic Kidney Disease Stage 3	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.113	ICD10 CM Chronic Kidney Disease Stage 4	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.114	ICD10 CM Chronic Kidney Disease Stage 5	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.115	AHA GWTG Chronic Kidney Disease Stage 1	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.116	AHA GWTG Chronic Kidney Disease Stage 3	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.117	AHA GWTG Chronic Kidney Disease Stage 4	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.118	SNOMED CT Atrial Fibrillation	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.119	ICD10 CM Atrial Fibrillation	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.121	AHA GWTG Atrial Fibrillation	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.123	SNOMED CT Hyperlipidemia	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.124	ICD10 CM Hyperlipidemia	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.125	AHA GWTG Hyperlipidemia	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.126	SNOMED CT Hypertriglyceridemia	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.127	ICD10 CM Hypertriglyceridemia	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.129	AHA GWTG Hypertriglyceridemia	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.130	SNOMED CT Gestational Diabetes	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.131	ICD10 CM Gestational Diabetes	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.132	AHA GWTG Gestational Diabetes	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.133	SNOMED CT Hyperglycemia	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.134	ICD10 CM Hyperglycemia	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.135	AHA GWTG Hyperglycemia	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.136	SNOMED CT Nonobstructive CAD	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.137	ICD10 CM Nonobstructive Coronary Artery Disease	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.138	AHA GWTG Nonobstructive coronary artery disease	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.139	AHA GWTG Anti Obesity Pharmacotherapy	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.15	Non Tobacco Smoking Product User	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.16	Antihypertensive Fixed Dose Combination Medications	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.2	PCSK9 Inhibitors	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.20	CCB and Thiazide and Thiazide Like Diuretics	active	2021-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.21	Referral to cardiac rehab	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.22	Cardiac Rehabilitation	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.25	2 Hour Blood Glucose Test	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.26	NYHA Functional Classification	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.27	ARNI Therapy	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.29	MRA Therapy	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.3	Cholesterol non HDL Laboratory Test	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.30	SGLT2 Inhibitors	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.31	Heart Transplant	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.32	Heart Transplant	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.33	Heart Transplant	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.34	Allergy to MRA Therapy	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.35	Aspirin or Clopidogrel	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.39	Cardiac Rehabilitation	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.4	Hypothyroidism	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.40	Cardiac Rehabilitation	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.43	SGLT2 Ingredients	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.44	MRA Ingredients	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.49	Minnesota Living with Heart Failure Questionnaire	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.5	Hypothyroidism	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.50	Kansas City Cardiomyopathy Questionnaire	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.51	Cardiac Pacer	active	2021-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.52	Cardiac Pacer	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.53	Cardiac Pacer	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.54	Heart Transplant Complications	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.55	Heart Transplant Complications	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.56	Heart Transplant Complications	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.57	Left Ventricular Assist Device Complications	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.58	Left Ventricular Assist Device Complications	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.59	Left Ventricular Assist Device Placement	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.6	Hypothyroidism	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.60	Left Ventricular Assist Device Placement	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.61	Left Ventricular Assist Device Placement	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.62	Left Ventricular Assist Device Placement	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.63	Heart Transplant	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.65	Cardiac Pacer	active	2022-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.66	Diastolic Heart Failure	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.67	Diastolic Heart Failure	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.68	Diastolic Heart Failure	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.69	Allergy to SGLT2 Inhibitors	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.7	Anorexia Nervosa	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.70	Intolerance to SGLT2 Inhibitors	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.71	Intolerance to MRA Therapy	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.72	ARNI Ingredient	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.73	Mitral Stenosis	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.74	Mitral Stenosis	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.75	Mitral Stenosis	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.76	Mechanical Prosthetic Heart Valve	active	2022-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.77	Mechanical Prosthetic Heart Valve	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.78	Mechanical Prosthetic Heart Valve	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.79	Mechanical Prosthetic Heart Valve in Situ	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.8	Anorexia Nervosa	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.82	Systolic Heart Failure	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.83	Systolic Heart Failure	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.84	Systolic Heart Failure	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.85	Carotid Intervention	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.86	Serum Creatinine	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.87	Urine Creatinine	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.88	Urine Albumin	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.9	Anorexia Nervosa	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.90	Non Steroidal Mineralcorticoid Receptor Antagonist	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.91	Glucagon like peptide 1 medications	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1178.96	AHA GWTG Long COVID19	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.1	Wound internal item and/or body structure visible value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.11	Wound exudate appearance value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.12	Wound exudate color value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.13	Exudate odor value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.16	Skin temperature value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.17	Skin color enumerated value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.18	Skin turgor value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.19	Skin and mucous membrane integrity value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.2	Periwound condition value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.20	Skin moisture value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.3	Wound Type Etiology value set	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.4	Wound episode value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.6	Wound bed appearance value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.60	Wound type reference set	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.7	Wound bed color value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.74	Nonverbal pain indicators reference set	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.76	Pain associated signs and symptoms reference set	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.77	Pain body location reference set	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.8	Wound edge description value set (foundation metadata concept)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.80	Pain quality reference set	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.81	Pain speed of onset reference set	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1181.9	Presence absence value set (foundation metadata concept)	active	2018-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1186.1	Common drug substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1186.2	Common drug classes for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1186.3	Common dietary substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1186.4	Common environmental substances for allergy and intolerance documentation	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.10	NHSNCriterionOfDiagnosisCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.11	NHSNCriterionOfDiagnosisCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.12	NHSNInfectionConditionCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.13	NHSNInfectionConditionCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.14	NHSNInfectionTypeCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.15	NHSNInfectionTypeCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.16	NHSNInfectionFirstReportedSource(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.17	NHSNInfectionFirstReportedSource(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.18	NHSNLOS/MENDischargeDisposition(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.19	NHSNLOS/MENDischargeDisposition(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.20	NHSNPopulationSummaryReportTypeCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.21	NHSNPopulationSummaryReportTypeCode(LOINC)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.22	NHSNSameDayOutcomeMeasure(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.23	NHSNSameDayOutcomeMeasure(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.24	NHSNSignificantPathogenCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.25	NHSNSignificantPathogenCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.26	NHSNSpinalFusionApproachCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.27	NHSNSpinalFusionApproachCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.28	NHSNVascularAccessTypeCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.29	NHSNVascularAccessTypeCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.30	NHSNVascularSpecimenCollectionSite(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.31	NHSNVascularSpecimenCollectionSite(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.38	Blood Glucose Laboratory and Point of Care Tests	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.6	NHSNPathogenCodeARO	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.63	Bacterial and Fungal Blood Culture Tests	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.7	NHSNRoleOfPerformerCode(CDCNHSN)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.74	Enteral Medication Route	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.75	Intravenous Medication Route	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.79	Fidaxomicin, Vancomycin, and Metronidazole	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.8	NHSNRoleOfPerformerCode(SNOMEDCT)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.85	Baloxavir	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.86	Peramivir	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.87	Zanamivir	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.88	Digestive, Intramuscular, Intravenous Route of Administration	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.9	NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)	active	2020-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.90	NHSN LTC AU Antimicrobial Agents	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.91	Long Term Care Discharge Disposition	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.94	NHSNNeurogenicBladder	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1190.95	NHSNSpinalCordInjury	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.147	SCIP Major Surgical Procedure	active	2019-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3483	Financial Insecurity Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3484	Food Insecurity Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3485	Health Literacy Screening Assessments Questions	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3486	Homelessness Screening Assessments Questions	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3487	Housing Instability Screening Assessments Questions	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3488	Less Than High School Education Screening Assessments Questions	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3519	Health Insurance Coverage Status Screening Assessments And Questions	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.3520	Inadequate Housing Screening Assessments And Questions	active	2023-07	hl7